Get the app
US › Healthcare

XBiotech Inc (XBIT)

US · Healthcare · Biotechnology

$2.18+1.40%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-6.7M
EPS
$-0.22

Key statistics

Market cap
$65.5M
Forward P/E
0.0
P/B
0.52
Book value
$4.21
EPS (TTM)
$-1.48
52-week high
$3.44
52-week low
$2.09
50-day MA
$2.27
200-day MA
$2.38
Beta
0.85

Analyst view

with an average price target of $18.00.

Shareholding

Insiders
24.33%
Institutions
6.73%

Largest institutional holders

FundStake
BlackRock Inc0.96%
Geode Capital Management, LLC0.76%
Vanguard Capital Management, LLC0.66%
RBF LLC0.65%
Morgan Stanley - Brokerage Accounts0.54%
Bridgeway Capital Management, LLC0.32%
Vanguard Fiduciary Trust Co0.30%
Millennium Management LLC0.26%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for XBiotech Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.